PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Li–Ng M et al. – This review critically assesses the evidence that support the use of conivaptan for the treatment of patients with euvolemic and hypervolemic hyponatremia. Conivaptan is effective in raising serum sodium levels in a predictable and safe fashion in euvolemic and hypervolemic hyponatremic patients. Conivaptan provides the first molecularly targeted approach for correcting hyponatremia in hospitalized patients.

Related Articles

Hyponatremia in Neurosurgical Patients: Clinical Guidelines Development
Neurosurgery, 10/26/09    Relevance Score: 90%

Prevention of Hyponatremia during Maintenance Intravenous Fluid Administration: A Prospective Randomized Study of Fluid Type versus Fluid Rate
The Journal of Pediatrics, 10/13/09    Relevance Score: 88%

Hyponatremia in Heart Failure
Journal of Intensive Care Medicine, 10/26/09    Relevance Score: 85%

New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children
Pediatric Nephrology, 11/11/09    Relevance Score: 80%

Today in Clinical Pharmacology...keeping you current

Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/16/09

Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: Opinions of Saskatchewan family physicians
Canadian Family Physician, 12/16/09

Taking the stress out of managing gout
Canadian Family Physician, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address